KRM Ayurveda IPO

Listed SME Ayurveda & Healthcare
Min Investment
₹2,70,000
2000 Shares
Min Investment
₹2,70,000 · 2000 Shares
Price Band ₹129–135
Lot Size 1000 shares
Issue Size ₹77 Cr
Listed At ₹180.70 +33.9%
Subscribed 74.43×
Listed On NSE SME

KRM Ayurveda IPO Listing Day Performance

KRM Ayurveda listed on NSE SME on 29 January 2026 at ₹180.70, a 33.85% premium over the issue price of ₹135. A retail investor allotted the minimum application of 2,000 shares (2 lots) gained ₹91,400 at the listing price.

Issue price
₹135
final price
Listing price
₹180.70
pre-open auction
Listing gain
+33.85%
+₹45.7 per share
Profit per application
+₹91,400
2,000 shares

GMP vs actual listing

Last GMP before listing₹45 (+33.3%)
GMP-implied listing₹180
Actual listing₹180.70
Difference+₹0.7 (+0.4%)

Demand going into listing

Subscribed overall74.43×
QIB63.31×
NII136.1×
Retail54.21×
Listing price = opening price from the exchange's pre-open call auction on listing day. Watch live price

Market Sentiment

Grey Market Premium What is GMP?
+₹45
+33.3% ▲ ₹10 since last update
Est. listing ₹180
Issue price ₹135
GMP range ₹20 – ₹45
24 Jan · ₹20 28 Jan · ₹45
Updated 28 Jan, 12:00 am IST Unofficial grey-market data
GMP estimate ₹180
Actual listing ₹180.7
Listed above the GMP estimate by ₹0.7 (+0.4%)
Subscription Status
QIB
63.31x
NII
136.10x
bNII (>10L)
167.63x
sNII (2-10L)
73.04x
Retail
54.21x
Total
74.43x
Updated: Mar 03, 2026 9:50 pm IST
Analysis Score 65 / 100
Data: 80%
GMP Score · 44% weight 70
Subscription Score · 38% weight 60
Financial Health · 19% weight 61
Weighted average of the parts above; updates as GMP and subscription change. not investment advice.

IPO Details

Price Band₹129–135 per equity share
Face Value₹10 Per Equity Share
Lot Size 1000 shares (Min 2 lots · ₹2,70,000)
Total Issue Size ₹77.49 crore
Fresh IssueEntire issue — no offer for sale, so all proceeds go to the company
Issue TypeBook Build Issue
Lead Manager NEXGEN Financial Solutions Pvt. Ltd.
Registrar Skyline Financial Services Pvt. Ltd.
Listing atNSE SME
NSE SymbolKRMAYURVED
Listing Price₹180.70
Listing Gain+33.85%

Market Lot Size

Category Lots Shares Amount (₹)
Retail Minimum 2 2,000 ₹2,70,000
Retail Maximum 2 2,000 ₹2,70,000
S-HNI Minimum 3 3,000 ₹4,05,000
S-HNI Maximum 7 7,000 ₹9,45,000
B-HNI Minimum 8 8,000 ₹10,80,000

IPO Reservation

QIB 20% NII 15.1% Retail 35.1% Anchor 29.8%
Category Shares Offered Shares %
QIB10,32,00019.98%
NII (HNI)7,80,00015.10%
bNII > ₹10L5,20,00010.07%
sNII < ₹10L2,60,0005.03%
Retail18,12,00035.08%
Anchor15,42,00029.85%
Total51,66,000

Financial Analysis

Financial Data

ROE
67.86%
ROCE
43.33%
Debt/Equity
1.31
NAV/Share
₹1,602.40
Revenue Growth
13.88%
Profit Margin
15.72%

Financial Performance

2025 vs 2024 Revenue +13.9% Profit (PAT) +254.8% Total Assets +52.1%
Metric 2023 2024 2025 Sep 2025
Revenue 89.38 67.57 76.95 48.65
Expense 79.29 62.85 60.61 37.65
Profit (PAT) 7.60 3.41 12.10 8.14
Total Assets 39.48 43.91 66.79 78.12
Values in Crores (₹)

Peer Comparison

Company EPS P/E Market Cap (Cr)
Jeena Sikho Lifecare Ltd. 8.86 76.58 31
Vaidya Sane Ayurved Laboratories Ltd 3.07 93.20 5
Peer median P/E 84.9x across 2 listed peers

Promoters & Holding Pattern

Promoters: Mr. Puneet Dhawan and Mrs. Tanya Dhawan

Shareholding No. of Shares Holding %
Promoter Holding Pre Issue 1,55,20,800 92.16%
Promoter Holding Post Issue 2,12,60,800 67.28%

Strengths & Risks

Strengths
  • Strongly subscribed — 74.4x overall (final).
  • Strong institutional (QIB) demand — 63.3x.
  • Solid profit margin — 15.7%.
  • Strong return on equity — 68%.
Risks & Concerns
  • Elevated leverage — debt/equity of 1.31.
  • Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.

From this issue's live data. Not investment advice — read the RHP.

Company Information

KRM Ayurveda at a glance

From the company's description: “KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items.”

KRM Ayurveda is raising ₹77.49 crore through an IPO on the NSE Emerge (SME) in the Ayurveda & Healthcare sector. All of it is a fresh issue: there is no offer for sale, so every rupee raised goes to the company rather than to selling shareholders. Main stated uses of the fresh money: Working Capital Requirement (₹18 crore), Capital Expenditure for Construction and Development of Telemedicine Operational Facilities (₹13.67 crore) and Repayment/Prepayment of loan (₹12.5 crore).

Revenue went from ₹89.38 crore in 2023 to ₹76.95 crore in 2025, down 14% over 2 years. Profit after tax went from ₹7.6 crore to ₹12.1 crore, a net margin of 16% in the latest year.

The promoter, Mr. Puneet Dhawan and Mrs. Tanya Dhawan, holds 92% before the issue and 67% after it — a dilution of 24.9 percentage points. Debt stands at 1.31 times equity.

Written from the issue's offer-document figures shown on this page. Not investment advice.

Company Contact Information

KRM Ayurveda Ltd., A-16, G T Karnal road, North West Delhi, New Delhi, 110033

Objects of the Issue

Purpose Amount (Cr)
Capital Expenditure for Construction and Development of Telemedicine Operational Facilities 13.67
Purchase of CRM Software and Hardware Infrastructure 1.42
Human Resources 5.44
Repayment/Prepayment of loan 12.50
Working Capital Requirement 18.00
General Corporate Purpose -

Resources & Documents

Anchor Investors

Anchor Bidding Date
January 20, 2026
Shares Offered to Anchors
15,42,000
Lock-in End (30 Days, 50%)
February 26, 2026
Lock-in End (90 Days, 50%)
April 27, 2026

KRM Ayurveda IPO - Quick Take

KRM Ayurveda has set a price band of Rs 129–Rs 135 per share for an issue size of Rs 77 crore in the ayurveda & healthcare sector. The stock listed with a 33.85% gain versus its issue price on January 29, 2026.

The company operates in the ayurveda & healthcare space.

The issue is promoted by Mr. Puneet Dhawan and Mrs. Tanya Dhawan with NEXGEN Financial Solutions Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards capital Expenditure for Construction and Development of Telemedicine Operational Facilities (Rs 14 crore) and purchase of CRM Software and Hardware Infrastructure (Rs 1 crore).

On fundamentals, the company is posting revenue growth of 13.9%, a profit margin of 15.7%, return on equity of 67.9% in its most recent reported period. Listed peers in this segment include Jeena Sikho Lifecare Ltd. (P/E 76.58x, market cap Rs 31 crore) and Vaidya Sane Ayurved Laboratories Ltd (P/E 93.20x, market cap Rs 5 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.

On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.

KRM Ayurveda IPO: Lead Manager & Registrar Track Record

How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out KRM Ayurveda itself, so they describe what came before it.

SME IPOs, last 12 months
  • KRM Ayurveda listed at +33.9% on day one; the median of 193 listings was +1.5% (better than 82% of them).
  • Subscribed 74.43x against a median of 3.98x across 192 issues (higher than 74%).
  • Average listing-day move across all 194 SME listings we track: +11.6%.
Lead manager and registrar record on other IPOs we track
Firm Other IPOs Listed at / above issue Avg move Median
NEXGEN Financial Solutions Pvt. Ltd. Lead manager 5 0 MB · 5 SME 60% 3 of 5 +15.8% +2.9%
Skyline Financial Services Pvt. Ltd. Registrar 16 0 MB · 16 SME 69% 11 of 16 Check allotment →
Recent listings managed by NEXGEN Financial Solutions Pvt. Ltd. (5)

Best: IC Electricals +67.7% · Weakest: Manilam Industries −20%

IPOListedListing-day move
Shakti Polytarp 22 Sep 2026 −0.2%
Optimystix Entertainment 14 Aug 2026 +2.9%
IC Electricals 10 Jul 2026 +67.7%
Manilam Industries 27 Feb 2026 −20%
Defrail Technologies 19 Jan 2026 +28.4%
What a lead manager does

A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.

What a registrar does

Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.

Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.

Frequently Asked Questions

KRM Ayurveda listed at Rs 180.70 on 29 January 2026, against an issue price of Rs 135 — a 33.85% premium.

+33.85% at the listing price — Rs 45.7 per share, or Rs 91,400 on the minimum retail application of 2,000 shares.

The price band of KRM Ayurveda IPO is Rs 129 to Rs 135 per share. Face value is Rs 10 per share.

The total issue size of KRM Ayurveda IPO is Rs 77 crore, comprising fresh issue of Rs 77 crore.

The lot size of KRM Ayurveda IPO is 1,000 shares. The minimum application is 2 lots (2,000 shares), requiring an investment of Rs 2,70,000.

KRM Ayurveda IPO opens for subscription on January 21, 2026 and closes on January 23, 2026. Anchor investor bidding is scheduled for January 20, 2026.

The expected allotment date for KRM Ayurveda IPO is January 27, 2026. Refunds for unsuccessful applicants are expected on January 28, 2026.

KRM Ayurveda IPO is scheduled to list on January 29, 2026 on NSE. NSE symbol: KRMAYURVED.

The last GMP (Grey Market Premium) recorded for KRM Ayurveda IPO before listing was +Rs 45 (+33.3% over issue price). The shares actually listed at Rs 180.7 (+33.85% versus the issue price). GMP only estimates the listing price and stops mattering once the shares trade.

KRM Ayurveda IPO was subscribed 74.43 times overall by the close of bidding — retail at 54.21x, QIB at 63.31x, NII at 136.10x.

Based on the final retail subscription of 54.21x for KRM Ayurveda IPO, the estimated retail allotment probability is approximately 2.1%. This is a low probability — approximately 2 out of every 100 retail applications may receive allotment.

The registrar for KRM Ayurveda IPO is Skyline Financial Services Pvt. Ltd. After the allotment date, you can check your allotment status on the registrar's official website by entering your PAN, application number, or demat account details. Allotment status is also available on the BSE and NSE websites.

The book running lead manager(s) for KRM Ayurveda IPO are NEXGEN Financial Solutions Pvt. Ltd.

The promoter(s) of KRM Ayurveda are Mr. Puneet Dhawan and Mrs. Tanya Dhawan.

KRM Ayurveda IPO GMP — What It Means

Its last GMP before listing was 33.3%. Of the 34 SME IPOs we have tracked with a final GMP of 25% or more, 34 listed above, 0 flat and 0 below the issue price; KRM Ayurveda listed 33.9% above its issue price.

See the full KRM Ayurveda GMP history and trend, or learn how grey market premium works and how reliable it is.

Related IPO

Same sector or same stage as KRM Ayurveda
Side by side: GMP, subscription, valuation, financials and listing performance.
0 Comments

No comments yet. Be the first to share your opinion!

GMPUpdate